Interindividual variation in the expression of tumor necrosis factor ␣ (TNF) suggests the existence of functionally distinct TNF alleles that could play a role in susceptibility to TNF associated diseases such as rheumatoid arthritis (RA). To determine whether differential expression of TNF alleles exists, the relative contribution of TNF alleles in total TNF RNA production in peripheral blood mononuclear cells (PBMC) of healthy individuals and synovial tissue of RA patients was analyzed. By using a Tai I restriction fragment length polymorphism (RFLP) located at position +489 in the first intron of the gene, the relative contribution of each allele in precursor transcript production in heterozygous individuals could be measured. By means of this method we studied whether differences exist between TNF alleles in TNF pre-mRNA production. The relative contribution of TNF alleles to the non-spliced RNA pool was measured in PBMC of healthy individuals which were stimulated with LPS, PMA and anti-CD3 and anti-CD28 monoclonal antibodies for different time periods. Moreover, synovial biopsy material of RA patients was analyzed. The results of this study do not reveal a difference in the contribution of distinct TNF alleles in TNF pre-mRNA production upon in vitro and physiological stimulation conditions in healthy individuals and RA patients. Since some of the individuals whose PBMC were tested were also heterozygous for either −308, −1031, −863, −857 TNF promoter/enhancer single nucleotide polymorphisms (SNPs), the data argue against functional relevance of these TNF promoter/enhancer SNPs in the regulation of transcription. In conclusion, the data do not provide evidence for the existence of transcriptionally distinct TNF alleles to explain interindividual variation in TNF expression. Genes and Immunity (2001) 2, 135-144.
Introduction
The cytokine tumor necrosis factor ␣ (TNF) is a pivotal factor in inflammation that may exert beneficial or deleterious effects, depending on the timing, localization and extent of its release. It plays a critical part in initiating and regulating the cytokine cascade during an inflammatory response and is involved in the pathogenesis of various infectious and autoimmune diseases like rheumatoid arthritis (RA). 1 Evidence for this stems from studies with TNF transgenic mice that developed chronic arthritis 2 and clinical studies showing that treatment of RA patients with anti-TNF monoclonal antibodies resulted in remarkable ameliorative effects. 3 been demonstrated and evidence exists that the individual TNF responsiveness is genetically determined. [4] [5] [6] [7] Several studies suggested an association of differences in TNF production with polymorphic sites on chromosome 6 where the TNF gene is located. These data could be explained by the existence of functionally relevant polymorphisms in the TNF gene. The search for genetic heterogeneity within the TNF gene has indeed disclosed several polymorphisms in the 5Ј regulatory region. [8] [9] [10] [11] [12] [13] [14] [15] Of the reported gene variants, the TNF −308 and −238 single nucleotide polymorphisms (SNPs) have been associated with susceptibility or/and severity of disease. 11, [16] [17] [18] [19] [20] [21] [22] [23] Disease associations might be explained by assuming functional significance of these SNPs. However, since chromosome 6 is highly polymorphic and characterized by extensive linkage disequilibrium the possibility exists that these SNPs are markers of a haplotype rather than themselves responsible for the disease association. In order to demonstrate functional relevance of disease associated TNF SNPs, several groups have performed transfection assays with plasmids harboring the TNF promoter alleles driving the expression of a reporter gene. Results from our group and others indicated that the −308 polymorphic nucleotide does not have a significant effect upon TNF expression. 15, 24, 25 At variance with these reports, several other groups reported that the −308 variant caused a significant increase in TNF transcription. 12, [26] [27] [28] In addition, studies demonstrating functional relevance of the −376, −863 and −857 TNF SNPs 14, 29 could not be confirmed by others. 15, 23 In summary, no consensus concerning functional significance of the TNF SNPs could be made from these conflicting reports.
In general, each of the two genes in a diploid organism contribute equally to the total mRNA production. However, exceptions can arise when mutations alter allelespecific steady state mRNA. The presence of such functionally distinct TNF alleles would lead to an unequal contribution of each allele to the total TNF mRNA production. The intragenic G to A transition polymorphism at position +489 relative to the transcription start site of the human TNF gene 30 provides the opportunity to distinguish the allelic pre-mRNA products. This polymorphism creates a Tai I RFLP that enables the determination of possible functional genetic heterogeneity between TNF alleles. Based on the fact that this restriction fragment length polymorphism (RFLP) is present in precursor mRNA, a method was developed to measure the relative contribution of each TNF allelic transcript within the total pool of non-spliced RNA in individuals heterozygous for this Tai I RFLP. This method, called allele-specific transcript quantification (ASTQ) analysis, was applied to directly and definitively measure the expressional representation of different allelic TNF transcripts in healthy individuals and RA patients. Determination of differences in transcription between TNF alleles in vivo may provide insight in the genetic mechanism underlying interindividual variation in TNF production.
Results

Genotyping of TNF polymorphisms
In a panel of 63 randomly selected unrelated, healthy individuals 13 individuals were genotyped TNF+489 GA as determined by the procedure outlined in Figure 1 . The genotype frequencies of TNF+489 GG (0.79) and TNF+489 GA (0.21) in this group of healthy individuals are in accordance with those earlier reported. 30, 31 No TNF+489AA homozygous individuals were present in this group. All individuals were genotyped TNF−238GG. Genotyping for TNF−308 revealed that five out of the 13 TNF+489GA individuals were also TNF−308GA. Sequence analysis data of subcloned TNF alleles revealed that in these five individuals the TNF+489 A variant is linked with a G at position −308. Eleven out of these 13 healthy individuals were included in this study.
In the group of 293 patients with RA analyzed 34 patients were heterozygous for TNF+489. Synovial biopsy material was obtained from two patients by knee arthroscopy and subjected to ASTQ analysis. Characteristics and genotypes of the individuals included in this study are given in Table 1 .
Relative quantification of TNF+489G and +489A allelic DNA fragments: validation of procedure Since the TNF+489 SNP is located in the first intron it does not interfere with the TNF protein sequence but may have an influence on pre-mRNA expression and/or turnover. If it would have an effect on these processes, an alteration in the amount of allele-specific pre-mRNA is to be expected. As a consequence of the presence of the TNF+489 SNP within a part of the gene that is transcribed it is possible to discriminate between allelic transcripts in a +489 GA heterozygous individual. Since the TNF+489 SNP represents an RFLP, discrimination between the two allelic transcripts can be visualized by restriction endonuclease digestion of the RT-PCR products by Tai I. The ratio of the bands representing the allelic RT-PCR products reflects the ratio between the respective precursor transcripts. To validate this procedure, the intensities of the fragments in DNA mixtures with a known distribution of +489G and +489A alleles was measured. Figure 2a demonstrates that the ratio of the intensity of the bands equals the ratio in the DNA mixtures (R 2 = 0.9532). When genomic DNA of the heterozygous individuals was digested with Tai I following PCR, the ratio between the intensities of the two restriction fragments, after quantification by phosphorimaging, varies between 1:1.2 and 1:1.6 ( Figure 2b ). During our analyses (presented in Figures 2b, 3 , 4 and 5) a nearly consistent predominance of the TNF+489A allele was observed, represented by the undigested band of 392 bp. This is a result of heteroduplex formation during annealing in later cycles of the PCR reaction. Failure of Tai I to digest heteroduplexes will lead to a systematic bias in favor of the larger fragment. Experimental evidence for the occurrence of heteroduplex DNA during the PCR annealing reaction is presented in Figure 6 .
Although the inclusion of genomic DNA in our experiments confirms that these ratios reflect a 1:1 ratio in the starting material, the variability of heteroduplex formation reduces the accuracy of any quantification. We therefore devised an improved method that excludes heteroduplexes from the quantification.
We reasoned that all labelling methods that visualize the total product of a PCR reaction and depend on a restriction digest, will suffer from this artifact. A method that labels the product of only one denaturing/extension cycle will be free of visible heteroduplex formation and allow the correct quantification of allelic transcripts. Inclusion of a 32 P-radiolabeled dCTP in the final cycle of the PCR reaction labels the PCR product. Because this final PCR cycle-final cycle labelling (FCL)-is not followed by an additional denaturing step formation of heteroduplex DNA is now inhibited. Subsequent digestion with Tai I shows a ratio of TNF+489A/TNF+489G close to 1:1. In contrast, in a fully radioactive PCR performed on the same cDNA samples, heteroduplex formation disturbs TNF+489A/TNF+489G ratios ( Figure 6 ).
The FCL methodology was used in the further analysis of six healthy individuals (HE1, HE4, HE6, HE7 HE8, HE9) representing three −308 GG and three −308 GA genotypes (see Table 1 ).
Quantitative discrimination between the +489 allelic pre-mRNAs in stimulated peripheral blood mononuclear cells (PBMC) in healthy individuals. To determine the relative contribution of each allele to the total TNF pre-mRNA production PBMC of healthy heterozygous individuals were stimulated with different reagents to induce TNF production. For selective induction of TNF production by monocytes/macrophages PBMC were stimulated for 4 h with LPS. Anti-CD3 together with anti-CD28 for 4 and 24 h were used to specifically induce TNF production by T cells. Stimulation of PBMC with PMA for 4 h was used to induce TNF production in a broad spectrum of cells. All these stimulation conditions led to considerable induction of TNF production (2-5 ng/ml) (data not shown). After stimulation total RNA was isolated, treated with RNAse free DNAse I, and reverse-transcribed into cDNA. A 551 bp fragment ranging from +48 to +598 was amplified by PCR and analyzed. Results of ASTQ analyses in healthy individuals are shown in Figure 3 [HE1-HE6]. Quantification of the respective TNF+489G and TNF+489A allelic DNA bands revealed that the ratio TNF+489A:TNF+489G ranged from 1:1 to 1:1.6 in pre-mRNA (Table 1) . No significant differential effects of the various stimuli used to induce TNF transcription were seen in PBMC of the healthy individuals. Analysis of pre-mRNA from six healthy individuals using the FCL methodology gave similar results (Table 2 ). This indicates that both TNF alleles contribute equally to the pre-mRNA pool.
Genes and Immunity
Quantitative discrimination between the +489 allelic pre-mRNAs in synovial biopsies of RA patients The possibility remains that differences in the expression of TNF alleles becomes prominent upon a specific physiological TNF-inducing agent involved in RA. Since the in vivo TNF inducing agent in RA is unknown, the only way to investigate this matter is to analyze allelic TNF transcription in in vivo stimulated tissue. For this purpose, synovial tissue known to express abundant TNF mRNA was obtained from the knee by arthroscopy of two TNF+489 heterozygous RA patients. RNA was isolated from the synovial tissue and ASTQ analysis was performed as described above. No significant difference in the capacity of each TNF allele to contribute to the premRNA pool in inflamed synovial tissue of the two RA patients could be detected (see Figure 4 ).
Discussion
Associations of TNF SNPs with infectious and autoimmune diseases could be explained by functionality of SNPs in or nearby the TNF locus or genetic linkage of these SNPs with disease-causing gene(s). Different approaches have been successfully applied for several genes to study the allelic mRNA production. 32, 33 Allelespecific quantification of TNF transcripts could provide insight into whether variation between TNF genes, resulting in differential RNA production, exists. The Tai I RFLP, created by the TNF+489 G to A transition polymorphism, may be useful for studying possible variation in allelic TNF transcription. This methodology yields a relative measure of transcript accumulation from distinct TNF alleles without standardization to a reference transcript. In this study, we show that each TNF allelic transcript contributes essentially equally to the pre-mRNA pool in both PBMC of heterozygous healthy individuals and synovial tissue of RA patients, a finding which is not supportive for the existence of transcriptionally distinct TNF alleles.
The TNF+489 variant has only recently been described. 30 Association of the uncommon TNF+489A allele in a subgroup of common variable immune deficiency (CVID) patients with granulomatous complications 34 suggested that the presence of TNF+489A, or associated alleles, results in higher TNF production in these patients. In RA a significant decrease of the uncommon TNF+489A allele has been demonstrated. Patients carrying the TNF+489A allele were shown to suffer from a less severe disease course. 31 In contrast with CVID, the protective effect of TNF+489A in RA might be explained by a reduced production capacity of the TNF+489A allele. Here it is demonstrated that TNF+489 heterozygous healthy individuals have a nearly equal contribution of TNF allelic transcripts to the total non-spliced RNA pool when stimulated with in vitro TNF inducing agents as determined by ASTQ analysis. These observations suggest the absence of functional significance for this particular TNF gene variant. Furthermore, ASTQ analysis of TNF premRNA in synovial biopsy material of RA patients did not reveal significant differences in TNF pre-mRNA production. In material of these patients, TNF expression was induced by an unknown physiological stimulus. Taken together, these data suggest the absence of significant intrinsic differences in the TNF gene that influence the capacity of each TNF allele to synthesize non-spliced RNA. Moreover, it may be concluded that transcriptional differences between the respective TNF genes is not a hallmark of RA. These findings confirm and extend data from ASTQ analysis using the C-insertion polymorphism at position +70 in the 5Ј UTR of the TNF transcript 35 where due to the low frequency of the TNF+70C heterozygous healthy individuals only a small number of individuals were tested. These results are also in agreement with data on comparative expression of TNF alleles from normal and autoimmune-prone murine MHC haplotypes. 36 However, due to the limitations in the accuracy of measurement of the relative transcript contribution, we cannot formally exclude the possibility that slight differences (lower than approx 1:1.5) in allelic TNF transcript production exist. Amiot et al 37 propose that small nonsignificant differences in transcript production could have some biological effect.
Genotyping of the subjects revealed that several TNF alleles were represented in this study. Besides heterozygosity for TNF+489, some of the healthy individuals included in this study were also heterozygous for TNF−308GA, TNF−863CA, TNF−857CT or/and TNF−1031TC. Data obtained with ASTQ analysis of the different TNF alleles do not point to regulatory effects of these polymorphisms on TNF gene transcription and show that the alleles are functionally similar. Since all five −308A alleles tested were linked to the +489G alleles we formally cannot exclude the possibility of a confounding effect. Transient transfection assays comparing variant TNF enhancer/promoter reporter gene constructs are commonly applied to study transcriptional functionality of TNF SNPs. The advantage of ASTQ analysis over reporter gene studies is that it is closer to the in vivo situation, avoiding the use of artificial constructs, cell lines, and the problematic transfection methodology. While many studies have claimed to show differential transcription of SNP constructs, these data have not been supported by techniques similar to ASTQ, leaving open the question of the physiological significance of these results.
Regarding the controversy on functionality of TNF gene polymorphisms, the results obtained in this study are in favor of reports that could not demonstrate functionality of TNF gene variants in in vitro systems. 15, 24, 25 This analysis is confined to events that occur at the regulation of pre-mRNA production, which includes processes such as transcription and pre-mRNA turnover. Although our results indicate that these events are not likely to be subject to variation, other mechanisms may account for the differential production seen between individuals. In this respect variation in TNF segments that influence post-transcriptional regulation, such as mRNA stability, may explain the difference. However, extensive search for sequence variation in such TNF gene segments (eg, TNF 3Ј UTR) has yet to reveal genetic differences. 38 Alternatively, tightly linked and yet unidentified alleles at other loci may modify the TNF production. Since TNF production has been suggested to be MHC associated, a major component responsible for differential TNF production may reside within the MHC locus. Interesting candidate genes located in this locus are SAPK-2 (stress activated protein kinase-2) 39 and the I-kB/NF-kB-like genes Ikbl 40 and G9a 41 that may play crucial roles in inducible transcriptional gene activation. Mutations affecting the expression of these genes or the activity of their gene products could have impact on TNF gene expression and could therefore indirectly be responsible for the observed MHC associated interindividual differences in TNF production.
In conclusion, this study does not provide evidence for the existence of transcriptionally distinct TNF alleles to explain either interindividual variation in TNF expression or the extensive association of these alleles with human disease. Furthermore, these data do not indicate the presence of differences in TNF transcript production between TNF alleles in RA.
Subjects, materials and methods
Subjects
The frequency of the TNF+489 SNP was determined in 63 randomly selected, unrelated healthy individuals and in 293 patients with RA. All patients fulfilled the American College of Rheumatology criteria of 1987 for RA. 42 PBMC from 11 healthy individuals were isolated by Ficoll-Hypaque density centrifugation. Synovial biopsy material was obtained from two RA patients by knee arthroscopy.
Genes and Immunity
Genotyping of TNF polymorphisms PCR amplification of genomic DNA was performed on a Perkin-Elmer thermal cycler (PE9600, PE-Cetus, Norwalk, CA, USA) in 40 l reaction mixtures containing 100 ng of test DNA, 50 mm KCl, 10 mm Tris-HCl, 2 mm MgCl 2 , 2.4 g BSA, 0.1 mm of each dNTP, 10 pmol of each primer and 0.8 units of Taq polymerase (PerkinElmer Cetus). The following cycling conditions were used: 95°C 5 min; 35 cycles of 95°C 1 min, 60°C 1 min, 72°C 1 min; 72°C 7 min.
To type for TNF+489, PCR products generated with primers A and B (Table 3) were digested for 4 h at 65°C with 5 units of Tai I (MBI Fermentas, Germany) and size separated on a 2% agarose gel. The +489 G to A substitution leads to loss of a Tai I restriction site, hence the +489 G allele gives rise to fragments at 111, 159 and 281 bp, and the +489 A allele has bands at 159 and 392 bp (see Figure 1) . Genotyping of the −308 and −238 SNPs was carried out as previously described. 43 Genotyping of the −1031, −863, −857 SNPs was carried out by sequencing PCR products generated with primers C and D using the Circumvent thermal cycle DNA sequencing kit (New England Biolabs, Beverley, MA, USA). Genotypes of the individuals used in the ASTQ analysis were confirmed by dideoxy sequencing.
PBMC stimulation, RNA purification
Stimulation of the PBMC (3-5 × 10 6 per condition) was performed using LPS (1 g/ml) and PMA (10 ng/ml) for 4 h at 37°C under a 5% CO 2 atmosphere. For stimulation of T lymphocytes, PBMC were stimulated for 4 and 24 h with anti-CD3 (CLB-T3/4.E) and anti-CD28 (CLB-CD28/1) monoclonal antibodies at final concentrations of 0.2 g/ml and 5 g/ml respectively. Following stimulation, cells were washed with PBS and RNA was isolated by RNAzol B treatment (Cinna/biotech, Houston, TX, USA) as directed by the manufacturer. RNA from synovial biopsy material was isolated by the method of Chomczynski and Sacchi. 44 cDNA synthesis, RT-PCR As the +489 polymorphism is present in pre-spliced RNA it is not possible to distinguish PCR products resulting from cDNA synthesis from those originating from genomic DNA. It is therefore essential to remove all contaminating DNA before cDNA synthesis. RNA was treated with 1 unit RQ1 RNAse-Free DNAse/g RNA for 1 h at 37°C and further processed according to the manufacturers protocol (Promega, Leiden, The Netherlands). RNA samples were then divided equally and used in reverse transcriptase (RT) positive and RT negative reactions (1.5 g per reaction) to verify that PCR products were derived from cDNA. cDNA was synthesized with 500 ng random hexamers (Promega) per g total RNA, using 20-200 units MMLV-RT (Life Technologies, Breda, The Netherlands). RT-PCR was performed using either primers A and B, or E and F. All PCR amplifications were carried out under the same or similar conditions as for the genotyping of TNF+489.
Allele-specific quantification of TNF transcripts RT-PCR products were purified using phenol/ chloroform extraction or used directly. The amplicons were digested for 4 h at 65°C with 5 units of Tai I, separated by size on a 2% agarose gel and blotted onto Hybond N + Figure 5 Determination of the relative contribution of the two −308 allelic forms in PBMC stimulated with LPS (1 g/ml), PMA (10 ng/ml), aCD3/aCD28 (0.2 g/ml / 5 g/ml) of five healthy individuals heterozygous for both TNF +489 and TNF −308.
nylon transfer membrane (Amersham-Pharmacia, Roosendaal, The Netherlands). A 32 P-radiolabeled Tai I fragment of 281 bp was used as a probe. Southern blotting and hybridization were carried out according to standard laboratory methods. 45 Membranes were exposed for 30 min to 2 h according to the intensity of the signals to a Molecular Dynamics (MD) Phosphor screen. Data were obtained by scanning the exposed screen with a MD PhosphorImager and computer analyzed (ImageQuant, MD. Sunnyvale, CA, USA). The ratios of the +489G/+489A allele-derived transcripts was determined by calculating the pixel values of the 281 and 392 bp digestion fragments. Since the values for these two bands reflect the synthetic products from a RT-PCR amplification of the same RNA preparation, controlling for variations in reaction conditions was unnecessary.
Final cycle labelling (FCL) methodology
Preparation of cDNA and RT-PCR were as described above, using primers E and F. 5-8 l of a PCR reaction were incubated with 0.5 units of fresh Taq polymerase and 2 Ci 32 P dCTP and labelled in a single cycle with a 7-min denaturing step at 95°C, followed by a 2-min extension step at 55°C. Temperatures higher than 55°C were avoided to prevent heteroduplex formation in our PCR products. Products were directly digested with Tai I by adding 4 units plus 10× buffer to the mix, and incubating at 55°C for 1 h. Full digestion was monitored by the inclusion of PCR products from homozygote G/G genomic DNA, which showed 95-99% digestion.
Digested products were then run on either 3% agarose or 6% polyacrylamide gels, after which the gels were dried by hot air drying or on a gel dryer. Gels were Table 3 Positions and sequences of the oligonucleotides used in this study
Position Sequence
A +48/+67 5Ј-GGA GAG AAG CAA CTA CAG AC-3Ј B +598/+579 5Ј-CAC ACT TAG TGA GCA CCT TC-3Ј C −1115/−1096 5Ј-CAG AGA GCT TCA GGG ATA TG-3Ј D −543/−562 5Ј-TTG AGG CCT CAG GAA AGG CT-3Ј E +265/+283 5Ј-CGG TGC TTG TTC CTC AGC-3Ј F +541/+523 5Ј-CTC TTC CCC ATC TCT TGC-3Ј exposed as above for between 1 and 7 days, and quantified. The quantification was monitored by the inclusion of several genomic DNA G/A heterozygote controls which showed a ratio close to or equal to 1. The sequence-specific correction factor (based on G/C content of restriction products) for these PCR products was A/G 1.23.
Note
During the revision of this manuscript, Uejima H et al, 46 reported a PCR labelling method similar to our own FCL methodology.
